• Medientyp: E-Artikel
  • Titel: Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells
  • Beteiligte: Han, Fang; Liu, Guoqiang; Sun, Caifeng; Wei, Jienan
  • Erschienen: CMB Association, 2018
  • Erschienen in: Cellular and Molecular Biology, 64 (2018) 15, Seite 55-61
  • Sprache: Nicht zu entscheiden
  • DOI: 10.14715/cmb/2017.64.15.9
  • ISSN: 1165-158X; 0145-5680
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Multidrug resistance (MDR) poses a great impediment to cancer treatment. Excessive expression of ATP-binding cassette transport protein AC-1 (P-glycoprotein, P-GLP) is usually involved in MDR. In this study, ailanthone (AIL), a natural compound extracted from the whole seedlings of Ailanthus altissima (Simaroubaceae) was shown to mediate the reversal of P-GLP-induced MDR and restore the susceptibility of K562/A02 cells to doxorubicin (DOX). Further mechanistic studies revealed that AIL increased intracellular DOX accumulation and interrupted Rh123 efflux through suppression of P-GLP, and also suppressed P-GLP ATPase activity. At the same time, it markedly inhibited MDR1 gene expression and P-GLP protein to sensitize the cytotoxic effect of DOX. Furthermore, AIL down-regulated P-GLP expression by inhibiting the PI3K/Akt pathway. Thus, AIL could be a potential therapeutic compound for reversing P-GLP-mediated drug resistant cancer.
  • Zugangsstatus: Freier Zugang